# PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain

> **NCT07547605** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Kyrenia** · enrollment: 150 (estimated)

## Conditions studied

- Myofascial Pain Dysfunction Syndrome
- Trigger Points, Myofascial
- Trigger Point in Trapezius Muscle

## Interventions

- **OTHER:** Autologous Platelet-Rich Plasma (PRP)
- **DRUG:** PRP plus Betamethasone
- **DRUG:** Betamethasone (Diprospan)

## Key facts

- **NCT ID:** NCT07547605
- **Lead sponsor:** University of Kyrenia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547605, "PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07547605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*